Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Feinglos

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Diabetes Care|January 1, 1980
Immunologic reactions to insulinM N Feinglos
JAMA|November 3, 2001
Drug-induced hyperglycemiaB Luna, M N Feinglos
American Family Physician|May 16, 2001
Oral agents in the management of type 2 diabetes mellitusB Luna, M N Feinglos
Advances in Experimental Medicine and Biology|January 1, 1979
Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizideH Lebovitz, M N Feinglos
Metabolism: Clinical and Experimental|May 1, 1980
Sulfonylurea treatment of insulin-independent diabetes mellitusM N Feinglos, H E Lebovitz
American Heart Journal|October 28, 1999
Therapy of type 2 diabetes, cardiovascular death, and the UGDPM N Feinglos, M A Bethel
Lancet (London, England)|January 20, 1979
"Insulin" allergy due to zincM N Feinglos, B V Jegasothy
Annals of Internal Medicine|September 15, 1993
The benefit of increasing sulfonylurea doseM N Feinglos, C R Hollis
Diabetes Care|May 1, 1978
Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulnessH E Lebovitz, M N Feinglos
The Medical Clinics of North America|August 26, 1998
Treatment of type 2 diabetes mellitusM N Feinglos, M A Bethel
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Diabetes Care|January 1, 1980
Immunologic reactions to insulinM N Feinglos
JAMA|November 3, 2001
Drug-induced hyperglycemiaB Luna, M N Feinglos
American Family Physician|May 16, 2001
Oral agents in the management of type 2 diabetes mellitusB Luna, M N Feinglos
Advances in Experimental Medicine and Biology|January 1, 1979
Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizideH Lebovitz, M N Feinglos
Metabolism: Clinical and Experimental|May 1, 1980
Sulfonylurea treatment of insulin-independent diabetes mellitusM N Feinglos, H E Lebovitz
American Heart Journal|October 28, 1999
Therapy of type 2 diabetes, cardiovascular death, and the UGDPM N Feinglos, M A Bethel
Lancet (London, England)|January 20, 1979
"Insulin" allergy due to zincM N Feinglos, B V Jegasothy
Annals of Internal Medicine|September 15, 1993
The benefit of increasing sulfonylurea doseM N Feinglos, C R Hollis
Diabetes Care|May 1, 1978
Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulnessH E Lebovitz, M N Feinglos
The Medical Clinics of North America|August 26, 1998
Treatment of type 2 diabetes mellitusM N Feinglos, M A Bethel
Pageof 7